270 related articles for article (PubMed ID: 32448747)
21. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
[TBL] [Abstract][Full Text] [Related]
22. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia.
Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P
Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684
[TBL] [Abstract][Full Text] [Related]
23. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
Subramaniam RM; Karantanis D; Peller PJ
J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
[TBL] [Abstract][Full Text] [Related]
24. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
[TBL] [Abstract][Full Text] [Related]
25. [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by
Zhang MY; Ni JW; Ge JJ; Guan YH; Pei Z; Sun CJ; Wu J; Xu ZR; Yang L; Luo FH; Cheng RQ
Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):853-858. PubMed ID: 34587682
[No Abstract] [Full Text] [Related]
26. [Clinical, genetic, and radionuclide characteristics of the focal form of congenital hyperinsulinism].
Gubaeva DN; Melikyan MA; Ryzhkova DV; Poyda MD; Bairov VG; Sukhotskaya AA; Sokolov YY; Efremenkov AM; Mitrofanova LB; Christesen H; Nikitina IL
Probl Endokrinol (Mosk); 2019 Nov; 65(5):319-329. PubMed ID: 32202736
[TBL] [Abstract][Full Text] [Related]
27. Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children.
Mitrofanova LB; Perminova AA; Ryzhkova DV; Sukhotskaya AA; Bairov VG; Nikitina IL
Front Endocrinol (Lausanne); 2021; 12():710947. PubMed ID: 34497584
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography in congenital hyperinsulinism.
Mathur NB; Sharma M; Agarwal A; Kumar A
Indian Pediatr; 2011 Feb; 48(2):139-41. PubMed ID: 21378423
[TBL] [Abstract][Full Text] [Related]
29.
Boss M; Rottenburger C; Brenner W; Blankenstein O; Prasad V; Prasad S; Coppi P; Kühnen P; Buitinga M; Nuutila P; Otonkoski T; Hussain K; Brom M; Eek A; Bomanji J; Shah P; Gotthardt M
J Nucl Med; 2022 Feb; 63(2):310-315. PubMed ID: 34215672
[TBL] [Abstract][Full Text] [Related]
30. 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.
States LJ; Saade-Lemus S; De Leon DD
PET Clin; 2020 Jul; 15(3):349-359. PubMed ID: 32498990
[TBL] [Abstract][Full Text] [Related]
31. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
Garg PK; Putegnat B; Truong L; Reynolds C; Sanchez I; Nedrelow JK; Uffman J; Lokitz SJ; Nazih R; Garg S; Thornton PS
PLoS One; 2020; 15(10):e0241243. PubMed ID: 33108363
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
[TBL] [Abstract][Full Text] [Related]
33. The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography.
Hussain K; Seppänen M; Näntö-Salonen K; Adzick NS; Stanley CA; Thornton P; Minn H
J Clin Endocrinol Metab; 2006 Aug; 91(8):2839-42. PubMed ID: 16684819
[TBL] [Abstract][Full Text] [Related]
34. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
[TBL] [Abstract][Full Text] [Related]
35. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
36. ¹⁸F-DOPA PET/computed tomography imaging.
Chondrogiannis S; Marzola MC; Rubello D
PET Clin; 2014 Jul; 9(3):307-21. PubMed ID: 25030394
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic Resection of Pancreatic Tumors in Children: Results of a Multicentric Survey.
Esposito C; De Lagausie P; Escolino M; Saxena A; Holcomb GW; Settimi A; Becmeur F; van der Zee D
J Laparoendosc Adv Surg Tech A; 2017 May; 27(5):533-538. PubMed ID: 28225638
[TBL] [Abstract][Full Text] [Related]
38. Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: improving surgery and outcome in focal hyperinsulinism. Commentary to Mohnike et al.: Proposal for a standardized protocol for F-DOPA-PET (PET/CT) in congenital hyperinsulinism (Horm Res 2006;66:40-42).
Shield JP
Horm Res; 2006; 66(1):43-4. PubMed ID: 16710095
[No Abstract] [Full Text] [Related]
39. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis.
Blomberg BA; Moghbel MC; Saboury B; Stanley CA; Alavi A
Mol Imaging Biol; 2013 Feb; 15(1):97-105. PubMed ID: 22752652
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism.
Mohnike W; Barthlen W; Mohnike K; Blankenstein O
Semin Pediatr Surg; 2011 Feb; 20(1):23-7. PubMed ID: 21186000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
